Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes

Y Zhang, G Huang, Z Yuan, Y Zhang… - Frontiers in Cell and …, 2021 - frontiersin.org
Dilated cardiomyopathy (DCM) is a type of heart disease delimited by enlargement and
dilation of one or both of the ventricles along with damaged contractility, which is often …

Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression

J Cao, L Yuan - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Objective Hypertrophic cardiomyopathy (HCM) is a complex heterogeneous heart disease.
Recent reports found that long non-coding RNAs (lncRNAs) play an important role in the …

Early diagnostic clues of mucolipidosis type II: Significance of radiological findings

E Burgac, İ Kaplan, B Köseci, E Kara… - American Journal of …, 2024 - Wiley Online Library
Abstract Mucolipidosis type‐II (ML‐II) is an ultra‐rare disorder caused by deficiency of N‐
acetylglucosaminyl‐1‐phosphotransferase enzyme due to biallelic pathogenic variants in …

Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II

M Eyskens, L Bruyndonckx, ABP Van Kuilenburg… - JIMD …, 2023 - Wiley Online Library
We report a unique case of an infant with a severe dilated cardiomyopathy as the clinical
presentation of sialidosis type II (OMIM 256550), a rare autosomal recessive inherited …

Anaesthesia-Relevant Disease Manifestations and Perianaesthetic Complications in Patients with Mucolipidosis—A Retrospective Analysis of 44 Anaesthetic Cases …

LS Ammer, NM Muschol, R Santer, A Lang… - Journal of Clinical …, 2022 - mdpi.com
Mucolipidosis (ML) type II, intermediate, and III are lysosomal storage disorders with
progressive multiorgan manifestations predisposing patients to a high risk of perioperative …